Motley Fool Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-39,390
| Closed | -$1.6M | – | 224 |
|
|
2023
Q2 | $1.6M | Sell |
39,390
-390
| -1% | -$15.9K | 0.14% | 108 |
|
|
2023
Q1 | $1.93M | Sell |
39,780
-3,116
| -7% | -$151K | 0.21% | 81 |
|
|
2022
Q4 | $1.64M | Buy |
42,896
+6,425
| +18% | +$245K | 0.18% | 95 |
|
|
2022
Q3 | $1.83M | Sell |
36,471
-1,806
| -5% | -$90.7K | 0.18% | 92 |
|
|
2022
Q2 | $1.68M | Buy |
38,277
+5,351
| +16% | +$234K | 0.16% | 103 |
|
|
2022
Q1 | $1.23M | Sell |
32,926
-110,418
| -77% | -$4.12M | 0.09% | 136 |
|
|
2021
Q4 | $5.71M | Sell |
143,344
-7,407
| -5% | -$295K | 0.37% | 73 |
|
|
2021
Q3 | $5.61M | Buy |
150,751
+22,398
| +17% | +$833K | 0.36% | 69 |
|
|
2021
Q2 | $5.43M | Sell |
128,353
-6,900
| -5% | -$292K | 0.36% | 72 |
|
|
2021
Q1 | $6.4M | Buy |
135,253
+20,700
| +18% | +$980K | 0.46% | 62 |
|
|
2020
Q4 | $6.99M | Buy |
114,553
+20,700
| +22% | +$1.26M | 0.52% | 56 |
|
|
2020
Q3 | $4.59M | Buy |
93,853
+28,038
| +43% | +$1.37M | 0.41% | 64 |
|
|
2020
Q2 | $3.34M | Buy |
65,815
+5,698
| +9% | +$289K | 0.33% | 62 |
|
|
2020
Q1 | $2.68M | Buy |
60,117
+9,482
| +19% | +$423K | 0.35% | 59 |
|
|
2019
Q4 | $2.43M | Buy |
50,635
+28,190
| +126% | +$1.35M | 0.26% | 72 |
|
|
2019
Q3 | $759K | Buy |
+22,445
| New | +$759K | 0.09% | 118 |
|